Human Genome Epidemiology Literature Finder
|
Records 1 - 15 (of 15 Records) |
| Query Trace: Neoplasms and SRD5A1[original query] |
|---|
| Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk. American journal of epidemiology 2009 Nov 170 (10): 1241-9. Reding Kerryn W, Li Christopher I, Weiss Noel S, Chen Chu, Carlson Christopher S, Duggan David, Thummel Kenneth E, Daling Janet R, Malone Kathleen |
| Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jan 19 (1): 1. Setlur Sunita R, Chen Chen X, Hossain Ruhella R, Ha Jung Sook, Van Doren Vanessa E, Stenzel Birgit, Steiner Eberhard, Oldridge Derek, Kitabayashi Naoki, Banerjee Samprit, Chen Jin Yun, Schäfer Georg, Horninger Wolfgang, Lee Charles, Rubin Mark A, Klocker Helmut, Demichelis Frances |
| Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy. Breast cancer research and treatment 2012 Jan 131 (2): 653-61. Hein R, Abbas S, Seibold P, Salazar R, Flesch-Janys D, Chang-Claude |
| SRD5A polymorphisms and biochemical failure after radical prostatectomy. European urology 2011 Dec 60 (6): 1226-34. Audet-Walsh Etienne, Bellemare Judith, Nadeau Geneviève, Lacombe Louis, Fradet Yves, Fradet Vincent, Huang Shu-Pin, Bao Bo-Ying, Douville Pierre, Girard Hugo, Guillemette Chantal, Lévesque Er |
| Variation in genes encoding the neuroactive steroid synthetic enzymes 5a-reductase type 1 and 3a-reductase type 2 is associated with alcohol dependence. Alcoholism, clinical and experimental research 2011 May 35 (5): 946-52. Milivojevic Verica, Kranzler Henry R, Gelernter Joel, Burian Linda, Covault Jonath |
| Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709. Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant |
| Importance of 5a-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Feb 20 (3): 576-84. Lévesque Éric, Laverdière Isabelle, Lacombe Louis, Caron Patrick, Rouleau Mélanie, Turcotte Véronique, Têtu Bernard, Fradet Yves, Guillemette Chant |
| Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Jan 24 (1): 255-60. Penney Kathryn L, Sinnott Jennifer A, Tyekucheva Svitlana, Gerke Travis, Shui Irene M, Kraft Peter, Sesso Howard D, Freedman Matthew L, Loda Massimo, Mucci Lorelei A, Stampfer Meir |
| Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. Urologic oncology 2015 Jul 33 (7): 331.e1-7. Henríquez-Hernández Luis Alberto, Valenciano Almudena, Foro-Arnalot Palmira, Álvarez-Cubero María Jesús, Cozar José Manuel, Suárez-Novo José Francisco, Castells-Esteve Manel, Fernández-Gonzalo Pablo, De-Paula-Carranza Belén, Ferrer Montse, Guedea Ferrán, Sancho-Pardo Gemma, Craven-Bartle Jordi, Ortiz-Gordillo María José, Cabrera-Roldán Patricia, Rodríguez-Melcón Juan Ignacio, Herrera-Ramos Estefanía, Rodríguez-Gallego Carlos, Lara Pedro |
| Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial. Cancer 2016 May . Price Douglas K, Chau Cindy H, Till Cathee, Goodman Phyllis J, Leach Robin J, Johnson-Pais Teresa L, Hsing Ann W, Hoque Ashraful, Parnes Howard L, Schenk Jeannette M, Tangen Catherine M, Thompson Ian M, Reichardt Juergen K V, Figg William |
| Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health Study. Frontiers in oncology 2016 6 237. Christensen Carol H, Barry Kathryn Hughes, Andreotti Gabriella, Alavanja Michael C R, Cook Michael B, Kelly Scott P, Burdett Laurie A, Yeager Meredith, Beane Freeman Laura E, Berndt Sonja I, Koutros Stel |
| Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. International journal of clinical and experimental medicine 2015 8 (10): 19232-40. Poniah Prevathe, Mohamed Zahurin, Apalasamy Yamunah Devi, Mohd Zain Shamsul, Kuppusamy Shanggar, Razack Azad |
| Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis. Pathology, research and practice 2018 Apr . Xie Zu-Cheng, Li Tian-Tian, Gan Bin-Liang, Gao Xiang, Gao Li, Chen Gang, Hu Xiao-H |
| Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride. Cancer prevention research (Philadelphia, Pa.) 2019 Feb 12 (2): 113-120. Dai James Y, LeBlanc Michael, Goodman Phyllis J, Lucia M Scott, Thompson Ian M, Tangen Catherine |
| A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 11 169 115890. Stefan A J Buck, Marinda Meertens, Frederiek M F van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J H Coenen, Andries M Bergman, Stijn L W Koolen, Ronald de Wit, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijss |
- Page last reviewed:Feb 1, 2024
- Content source: